CBLN1 and coronary artery disorder: Another recent study [180] measured six previously identified high-risk plasma ceramide molecules [Cer(d18:1/16:0), Cer(d18:1/18:0), Cer(d18:1/20:0), Cer(d18:1/22:0), Cer(d18:1/24:0), and Cer(d18:1/24:1)] in 167 consecutive patients with established or suspected Coronary Artery Disease (CAD) who underwent either exercise or dypiridamole myocardial perfusion scintigraphy (MPS) for various clinical indications.